These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 33715385)

  • 21. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
    Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
    Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
    Tufan AC
    Curr Stem Cell Res Ther; 2021; 16(4):465-480. PubMed ID: 33238848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Main Mechanisms of Mesenchymal Stem Cell-Based Treatments against COVID-19.
    Li J; He S; Yang H; Zhang L; Xiao J; Liang C; Liu S
    Tissue Eng Regen Med; 2024 Jun; 21(4):545-556. PubMed ID: 38573476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.
    Raza SS; Khan MA
    Cytotherapy; 2022 Aug; 24(8):755-766. PubMed ID: 35880307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential of Mesenchymal Stem Cells for the Treatment of Cytokine Storm due to COVID-19.
    Li X; Yan M; Chen J; Luo Y
    Biomed Res Int; 2021; 2021():3178796. PubMed ID: 34840969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
    Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
    Front Immunol; 2021; 12():726909. PubMed ID: 34394132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
    Sahu KK; Siddiqui AD; Cerny J
    Lab Med; 2021 Jan; 52(1):24-35. PubMed ID: 32729620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial.
    Tao YC; Chen EQ
    Curr Stem Cell Res Ther; 2024; 19(1):55-62. PubMed ID: 36654468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
    Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
    Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges of mesenchymal stem cells in the clinical treatment of COVID-19.
    Li L; Zhang X; Wu Y; Xing C; Du H
    Cell Tissue Res; 2024 Jun; 396(3):293-312. PubMed ID: 38512548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.